期刊文献+

BRCA1和BRCA2在胶东半岛地区女性散发性乳腺癌中的表达研究 被引量:1

Expression of BRCA1 and BRCA2 in sporadic breast cancer in women of Jiaodong peninsula
原文传递
导出
摘要 目的 探讨BRCA1和BRCA2在胶东半岛地区女性散发性乳腺癌组织中的表达特点及其临床意义.方法 应用组织芯片技术及免疫组织化学方法检测100例胶东半岛地区女性散发性乳腺癌及30例乳腺良性病变组织中BRCA1和BRCA2的表达.结果 ①BRCA1和BRCA2的阳性表达率在乳腺癌组织中分别为49%(49/100)和50%(50/100);在乳腺良性病变中分别为80%(24/30)、83 33%(25/30).二者差异有统计学意义(P<0.05).②乳腺癌组织中BRCA1和BRCA2的表达与患者年龄、淋巴结转移状况、肿瘤的大小及绝经与否差异均无统计学意义(P>0.05).③BRCA1 和BRCA2 在乳腺癌中的表达无相关性.结论 BRCA1和BRCA2在胶东半岛地区散发性乳腺癌组织中的表达明显低于乳腺良性病变,可作为胶东半岛地区散发性乳腺癌监测指标,但在散发性乳腺癌发生发展中的作用是独立的,不具有相关性. Objective To study the expression and clinical significance of BRCA1 and BRCA2 in sporadic breast cancer in women of Jiaodong peninsula. Methods Immunohistochemistry and tissue array were used to detect the expression of BRCA1 and BRCA2 in 100 cases of sporadic breast cancer and 30 cases of benign breast tumor in women of Jiaodong peninsula. Results ① The expression rate of BRCA1 and BRCA2 was 49% (49/100) and 50% (50/100) in breast cancer, 80% (24/30) and 83.33% (25/30) in benign breast lesions respectively. The expression rate of BRCA1 and BRCA2 in breast cancer was lower than that in benign breast lesions (P〈0.05). ② The expression of BRCA1 and BRCA2 was uncorrelated with factors such as tumor size, lymphatic metastases, age and menopause or not(P〉0.05). ③ There was no dependency between the expression of BRCA1 and BRCA2 (P〉 0. 05). Conclusions The expression rate of BRCA1 and BRCA2 in breast carcinoma in women of Jiaodong peninsula was lower than that in benign breast lesions, suggesting that the expression of BRCA1 and BRCA2 was related to the occurrence of sporadic breast carcinoma in women of Jiaodong peninsula. However, the role of BRCA1 and BRCA2 in the genesis and development of the breast carcinoma is independent.
出处 《中华内分泌外科杂志》 CAS 2010年第5期295-298,共4页 Chinese Journal of Endocrine Surgery
关键词 散发性乳腺癌 BRCA1 BRCA2 Sporadic breast carcinoma BRCA1 BRCA2
  • 相关文献

参考文献9

二级参考文献36

  • 1宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.上海地区早发性乳腺癌患者BRCA1和BRCA2基因突变分析[J].中华医学杂志,2005,85(43):3030-3034. 被引量:26
  • 2Easton DF,Ford D,Bishop DT,et al.Breast and ovarian cancer incidence in BRCA1 mutation carriers:breast cancer linkage consortium[J].Am J Hum Genet,1995,56(1):265-271.
  • 3Wooster R,Bignel G,Lancaster J,et al.Identification of the breast cancer susceptibility gene BRCA2.[J].Nature,1995,378(6 559):789-792.
  • 4Alison W.New insights into the biological function of BRCA2 from its structural interactions[J].Breast cancer Res,2003,5(2):107-108.
  • 5Wilson JH,Elledge SJ.BRCA2 enters the fray[J].Science,2002,297(5 588):1 822-1 823.
  • 6Paula V.Breast Cancer-Predisposing genes in Finnish breast and ovarian cancer families[M].Helsinki,2001,14-16.
  • 7Wang X,Wang F,Taniguchi K.Truncating Variants in p53AIP1 Disrupting DNA Damage-Induced Apoptosis Are Associated with Prostate Cancer Risk[J].Cancer Res,2006,66(21):10 302-10 307.
  • 8Marcus JN,Page DL,Watson P,et al.BRCA1 and BRCA2 hereditary breast carcinoma phenotypes[J].Cancer,1997,80:543-556.
  • 9Malian H,Javier B,Jos P.The molecular pathology of hereditary breast cancer:genetic testing and therapeutic implications[J].Modern Pathology,2005,18:1 305-1 320.
  • 10Easton DF,Ford D,Bishop DT.Breast and ovarian cancer incidence in BRCA1-mutation cariesrs[J].Am J Hum Genet,1995,56(1):265-271.

共引文献20

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部